| Bioactivity | LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 and IPMK with IC50 values of 31 nM, 42 nM, 8.7 nM and 1944 nM, respectively. LI-2242 can be used for thew research of type II diabetes, obesity, metabolic complications, venous thrombosis, and psychiatric disorders[1]. |
| Target | IC50: 31 nM (IP6K1); 42 nM (IP6K2); 8.7 nM (IP6K3); 1944 nM (IPMK). |
| Invitro | LI-2242 对 IP6K1、IP6K2、IP6K3 和 IPMK 具有抑制作用，IC50 值分别为 31 nM、42 nM、8.7 nM 和 1944 nM[1]。 |
| Name | LI-2242 |
| CAS | 2762762-17-2 |
| Formula | C20H18Cl2N2O3 |
| Molar Mass | 405.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liao G, et al. Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening. ACS Pharmacol Transl Sci. 2021;4(2):780-789. Published 2021 Mar 3. |
LI-2242
CAS: 2762762-17-2 F: C20H18Cl2N2O3 W: 405.27
LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.